Analytical Data
-
Gene name
Ctf2
- Application
-
Alternative Names
Ctf2; Gm494Cardiotrophin-2; CT-2; Neuropoietin; Np
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P83714
-
Expression Region
23-204aa
-
AA Sequence
APISPSEP IGQAYSLALY MQKNTSALLQ TYLQHQGSPF SDPGFSAPEL QLSTLPSAAV SFKTWHAMED AERLSRAQGA FLALTQHLQL VGDDQSYLNP GSPILLAQLG AARLRAQGLL GNMAAIMTAL GLPIPPEEDT LGFVPFGASA FERKCRGYIV TREYGHWTDR AVRDLALLKA KYSA
-
Molecular Weight
22 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTF2, also known as Cytoplasmic Transport Factor 2, is a protein that plays a critical role in cellular processes, particularly in the transport and regulation of proteins involved in various signaling pathways. Research on CTF2 recombinant proteins has gained traction due to their potential applications in studying protein interactions, cellular signaling mechanisms, and the development of novel therapeutics. Recombinant protein technology allows for the production of CTF2 in a controlled environment, enabling researchers to investigate its structural and functional properties, understand its role in cellular processes, and explore its implications in diseases such as cancer and neurodegenerative disorders. Furthermore, recombinant CTF2 can serve as a valuable tool in biochemical assays and high-throughput screening for drug discovery, as it enables the detailed analysis of interactions between CTF2 and its binding partners. This research is crucial for elucidating the molecular mechanisms underlying various biological functions and for the advancement of targeted therapies that could improve patient outcomes in diseases associated with dysregulated protein transport. Overall, the study of CTF2 recombinant proteins represents a significant stride in the field of molecular biology and therapeutic development, emphasizing the importance of understanding intricate cellular mechanics for innovative medical intervention.
